Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116610
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2005-06-29
Brief Title:
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
Sponsor:
Poniard Pharmaceuticals
Organization:
Poniard Pharmaceuticals
Organization Data
Organization:
Poniard Pharmaceuticals
Class:
INDUSTRY
Study ID:
0402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Poniard Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None